Clinical Trials Browser

Phase EARLY_PHASE1 × Not yet recruiting × Nivolumab × Clear all

NCT07210632 2026-02-27

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Phase EARLY_PHASE1 Not yet recruiting

Brain Neoplasms, Glioma